[go: up one dir, main page]

GT199900087A - Terapia de combinacion para la fragilidad musculoesqueletica. - Google Patents

Terapia de combinacion para la fragilidad musculoesqueletica.

Info

Publication number
GT199900087A
GT199900087A GT199900087A GT199900087A GT199900087A GT 199900087 A GT199900087 A GT 199900087A GT 199900087 A GT199900087 A GT 199900087A GT 199900087 A GT199900087 A GT 199900087A GT 199900087 A GT199900087 A GT 199900087A
Authority
GT
Guatemala
Prior art keywords
combination therapy
musculoskeletal
fragility
musculoskeletal fragility
combination
Prior art date
Application number
GT199900087A
Other languages
English (en)
Spanish (es)
Inventor
Hua Zhu Ke
Mei Li
Lidia Codetta Pan
David Duane Thompson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900087A publication Critical patent/GT199900087A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GT199900087A 1998-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica. GT199900087A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
GT199900087A true GT199900087A (es) 2000-12-07

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900087A GT199900087A (es) 1998-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica.

Country Status (30)

Country Link
EP (1) EP1087764A1 (pt)
JP (1) JP2002518326A (pt)
KR (1) KR20010052852A (pt)
CN (1) CN1301160A (pt)
AP (1) AP9901582A0 (pt)
AR (1) AR018869A1 (pt)
AU (1) AU4054799A (pt)
BG (1) BG105041A (pt)
BR (1) BR9911324A (pt)
CA (1) CA2335134A1 (pt)
CO (1) CO5070587A1 (pt)
EA (1) EA200001186A1 (pt)
GT (1) GT199900087A (pt)
HN (1) HN1999000097A (pt)
HR (1) HRP20000859A2 (pt)
HU (1) HUP0102505A3 (pt)
ID (1) ID27599A (pt)
IL (1) IL138630A0 (pt)
IS (1) IS5691A (pt)
MA (1) MA26652A1 (pt)
NO (1) NO20006312L (pt)
OA (1) OA11505A (pt)
PA (1) PA8475901A1 (pt)
PE (1) PE20000646A1 (pt)
PL (1) PL344981A1 (pt)
SK (1) SK18912000A3 (pt)
TN (1) TNSN99124A1 (pt)
TR (1) TR200003544T2 (pt)
WO (1) WO1999065486A1 (pt)
ZA (1) ZA993975B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360103A1 (en) * 1999-02-08 2000-08-17 Robert Sladek Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
EP1156120B1 (en) 2000-05-08 2006-11-22 Pfizer Products Inc. Enzymatic resolution of selective estrogen receptor modulators
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2604943T3 (es) 2007-02-09 2017-03-10 Ocera Therapeutics, Inc. Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
SK18912000A3 (sk) 2001-10-08
AR018869A1 (es) 2001-12-12
CO5070587A1 (es) 2001-08-28
BG105041A (en) 2001-08-31
AU4054799A (en) 2000-01-05
MA26652A1 (fr) 2004-12-20
TNSN99124A1 (fr) 2005-11-10
PE20000646A1 (es) 2000-08-05
JP2002518326A (ja) 2002-06-25
WO1999065486A1 (en) 1999-12-23
AP9901582A0 (en) 1999-06-30
PA8475901A1 (es) 2000-05-24
EA200001186A1 (ru) 2001-06-25
KR20010052852A (ko) 2001-06-25
CA2335134A1 (en) 1999-12-23
IS5691A (is) 2000-10-27
ID27599A (id) 2001-04-12
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
HRP20000859A2 (en) 2001-04-30
EP1087764A1 (en) 2001-04-04
NO20006312D0 (no) 2000-12-12
NO20006312L (no) 2000-12-12
HN1999000097A (es) 1999-11-03
TR200003544T2 (tr) 2001-04-20
BR9911324A (pt) 2001-04-03
CN1301160A (zh) 2001-06-27
PL344981A1 (en) 2001-11-19
OA11505A (en) 2004-05-07
ZA993975B (en) 2000-12-15
HUP0102505A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
PA8521701A1 (es) Derivados de pirazol
GT199800158A (es) Agonistas de prostaglandinas.
PA8452701A1 (es) Agonistas de prostaglandinas
AR020021A1 (es) Composicion para el tratamiento de cancer usando aceites esenciales de plantas naturales con moduladores de transduccion de senal
ES2165441T3 (es) Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos.
BR9804437A (pt) Compostos para a osteoporose
PA8435201A1 (es) Derivados 6,6- o 6,7-biciclicos sustituidos que contienen pirido o pirimido.
CR9465A (es) Compuestos mejorados farmacocineticamente
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
AR011106A1 (es) COMPOSICIoN FARMACÉUTICA PARA EL TRAMIENTO O PREVENCI.ON DE LA DIABETES MELLITUS TIPO 2,
TR199902703T2 (xx) Proteaz inhibit�rleri.
GT199900087A (es) Terapia de combinacion para la fragilidad musculoesqueletica.
PT1105114E (pt) Composicoes farmaceuticas topicas contendo nimesulide
ES2096974T3 (es) Proceso de condensacion y/o equilibrio de compuestos organicos de silicio.
SE9801494D0 (sv) Novel use
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR9714049A (pt) Imidazopiridazinas
NO981019L (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
ES2176920T3 (es) Composiciones para el tinte de las fibras queratinicas que contienen para-aminofenoles, procedimiento de tinte, nuevos para-aminofenoles y su procedimiento de preparacion.
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
PT952975E (pt) Compostos bi-aromaticos ligados por um radical hetero-etinileno e composicoes farmaceuticas e cosmeticas que os contem
ES2186989T3 (es) Cristales de maltitol de formas especificas, compuestos cristalinos que los contienen y procedimientos para su preparacion.
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
MX9700298A (es) Adenovirus que comprende un gen que codifica para una no sintasa.